PathKeeper Surgical Achieves Outpatient Milestone, Validating Radiation-Free Navigation in ASC
The PathKeeper system is unique employing proprietary AI and ultra-high resolution 3D cameras to provide real-time surgical guidance. This eliminates the need for traditional radiation heavy intraoperative CT, delivering a crucial safety advantage. The system delivers verified sub-millimetric accuracy for registration and instrument tracking.
This successful adoption underscores Pathkeeper's unique qualification in the ASC market, a segment requiring highly efficient, low-footprint, and cost-effective enabling technology.
In commenting on the milestone, Dr.
About PathKeeper:
PathKeeper Surgical, an Israeli MedTech company, dedicated to improving spine and orthopedic surgical intervention using AI and specialized optics. Their core mission is to make navigation-guided surgery accessible in any operating room. The company continues its commitment to bringing next-generation, value-based enabling tech solutions worldwide.
Contact:
[email protected]
www.path-keeper.com
Photo: https://mma.prnewswire.com/media/2830685/Surgical_case_USPI_ASC.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/pathkeeper-surgical-achieves-outpatient-milestone-validating-radiation-free-navigation-in-asc-302624341.html
SOURCE PathKeeper
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with chronic lymphocytic leukemia (CLL) across all lines of therapy
- Mavenir Wins Deutsche Telekom's Partner of the Year Award for Best Network Innovation
- American Resources Corporation Set to Join Russell 3000(R) and Russell Microcap(R) Indexes
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share